News | 22/08/2023 | Award

Grant for research on cognitive function in down-syndrome associated Alzheimer’s

An international research team, including SyNergy member Johannes Levin, receives an 11 million grant from the National Institute on Aging (National Institutes of Health, NIH). The grant will fund the Down Syndrome – Ambulatory Research in Cognition study: an international collaboration that aims to build and validate novel assessment technology for clinical trials of people with Down syndrome-associated Alzheimer’s disease.

“It is of critical importance to give individuals with Down Syndrom access to high-level research on potential outcome measures for treatment trials and finally to treatment trials to prevent the development of symptomatic Alzheimer Disease”, explains Johannes Levin, leader of the neurodegenerative diseases group of the Department of Neurology at the Ludwig-Maximilians Universität München and the German Center for Neurodegenerative Diseases (DZNE). The research team includes researchers from the following other universities: the Washington University School of Medicine, King’s College London, Hospital Sant Pau in Barcelona, University of Gothenburg in Sweden, and Instituto Fleni in Buenos Aires.

More information about the grant and study can be found on the website of the Washington University School of Medicine in St. Louis: https://medicine.wustl.edu/news/cognitive-function-in-down-syndrome-associated-alzheimers-focus-of-grant/